BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17184645)

  • 21. Combination antiplatelet therapy with aspirin and clopidogrel: the role of antecedent and concomitant doses of aspirin. An analysis of 711 patients.
    Serebruany VL; Malinin AI; Atar D
    Cardiology; 2007; 107(4):307-12. PubMed ID: 17264511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case-control study of the association between polymorphisms of the endothelial nitric oxide synthase and glycoprotein IIIa genes and upper gastrointestinal bleeding in users of low-dose aspirin.
    Piazuelo E; Fuentes J; García-González MA; Jiménez P; Lanas A
    Clin Ther; 2008 Jan; 30(1):121-30. PubMed ID: 18343248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?
    Bliden KP; DiChiara J; Tantry US; Bassi AK; Chaganti SK; Gurbel PA
    J Am Coll Cardiol; 2007 Feb; 49(6):657-66. PubMed ID: 17291930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.
    Duzenli MA; Ozdemir K; Aygul N; Soylu A; Tokac M
    Am J Cardiol; 2008 Aug; 102(4):396-400. PubMed ID: 18678294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose effect of clopidogrel reloading in patients already on 75-mg maintenance dose: the Reload with Clopidogrel Before Coronary Angioplasty in Subjects Treated Long Term with Dual Antiplatelet Therapy (RELOAD) study.
    Collet JP; Silvain J; Landivier A; Tanguy ML; Cayla G; Bellemain A; Vignolles N; Gallier S; Beygui F; Pena A; Montalescot G
    Circulation; 2008 Sep; 118(12):1225-33. PubMed ID: 18765393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study.
    Velik-Salchner C; Maier S; Innerhofer P; Streif W; Klingler A; Kolbitsch C; Fries D
    Anesth Analg; 2008 Dec; 107(6):1798-806. PubMed ID: 19020120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The contribution of platelet glycoproteins (GPIa C807T and GPIba C-5T) and cyclooxygenase 2 (COX-2G-765C) polymorphisms to platelet response in patients treated with aspirin.
    Al-Azzam SI; Alzoubi KH; Khabour OF; Tawalbeh D; Al-Azzeh O
    Gene; 2013 Sep; 526(2):118-21. PubMed ID: 23688555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosing of clopidogrel for platelet inhibition in infants and young children: primary results of the Platelet Inhibition in Children On cLOpidogrel (PICOLO) trial.
    Li JS; Yow E; Berezny KY; Bokesch PM; Takahashi M; Graham TP; Sanders SP; Sidi D; Bonnet D; Ewert P; Jennings LK; Michelson AD;
    Circulation; 2008 Jan; 117(4):553-9. PubMed ID: 18195173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet hyperreactivity after coronary artery bypass grafting: the possible relevance to glycoprotein polymorphisms. A preliminary report.
    Golanski J; Golanski R; Chizynski K; Iwaszkiewicz A; Rozalski M; Wieclawska B; Boncler M; Watala C
    Platelets; 2001 Jun; 12(4):241-7. PubMed ID: 11454259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An evaluation of cyclooxygenase-1 inhibition before coronary artery surgery: aggregometry versus patient self-reporting.
    Rahe-Meyer N; Winterhalter M; Hartmann J; Pattison A; Hecker H; Calatzis A; Solomon C
    Anesth Analg; 2008 Dec; 107(6):1791-7. PubMed ID: 19020119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
    Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR
    Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin.
    Pettinella C; Romano M; Stuppia L; Santilli F; Liani R; Davì G
    Thromb Haemost; 2009 Apr; 101(4):687-90. PubMed ID: 19350112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estradiol increases platelet aggregation in Pl(A1/A1) individuals.
    Boudoulas KD; Montague CR; Goldschmidt-Clermont PJ; Cooke GE
    Am Heart J; 2006 Jul; 152(1):136-9. PubMed ID: 16824843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor.
    Lepäntalo A; Virtanen KS; Reséndiz JC; Mikkelsson J; Viiri LE; Karhunen PJ; Lassila R
    Thromb Res; 2009 Jun; 124(2):193-8. PubMed ID: 19232433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the T744C polymorphism of the P2Y12 gene on platelet response to a 600-mg loading dose of clopidogrel in 597 patients with non-ST-segment elevation acute coronary syndrome.
    Cuisset T; Frere C; Quilici J; Morange PE; Saut N; Lambert M; Camoin L; Vague IJ; Bonnet JL; Alessi MC
    Thromb Res; 2007; 120(6):893-9. PubMed ID: 17337040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of C807T, Pl(A), and -5 C/T Kozak genotypes with density of glycoprotein receptors on platelet surface.
    Huang T; Sahud MA
    Thromb Res; 2003; 112(3):147-50. PubMed ID: 14967411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological efficacy of low versus medium dose aspirin after coronary surgery: results from a randomized trial [NCT00262275].
    Lim E; Cornelissen J; Routledge T; Ali A; Kirtland S; Sharples L; Sheridan K; Bellm S; Munday H; Large S
    BMC Med; 2006 May; 4():12. PubMed ID: 16716214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet glycoprotein IIIa PlA1/A2 polymorphism and its relationship with diabetic nephropathy in type 2 diabetic patients.
    Scaglione L; Gambino R; Lillaz E; Bo S; Cassader M; Pagano G; Cavallo-Perin P
    Clin Nephrol; 2000 Apr; 53(4):253-6. PubMed ID: 10809411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic variation in platelet integrin alphabeta (GPIIb/IIIa) and the metastatic potential of renal cell carcinoma.
    Kallio JP; Mikkelsson J; Tammela TL; Karhunen PJ; Kellokumpu-Lehtinen P
    BJU Int; 2006 Jul; 98(1):201-4. PubMed ID: 16831169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk stratification after coronary artery bypass surgery by a point-of-care test of platelet function.
    Bevilacqua S; Alkodami AA; Volpi E; Cerillo AG; Berti S; Glauber M; Gianetti J
    Ann Thorac Surg; 2009 Feb; 87(2):496-502. PubMed ID: 19161767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.